Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can we not for a moment pause and reflect on our Flag (and that summer is around the corner). Happy Memorial Day God bless America and thanks again to our troops.
really looks higher tuesday and next week
thank you paul volume is pickin up monday being a holiday i am going to purchase a few more..great technology
This one looks interesting low volume of 28 thousand right now...i'll make an initial purchse now at the offer.
APS perhaps? something's up here
dont be surpsrised if BNTNF takes off real soon
just a heads up : BNTNF.ob is the one to OWN ASAP
i just got my APS special alert too....they said soon and as a subsciber i may get a second email first thing tomor....can't wait...
maybe time to have serious look under .05 but just too many shrs out to move no? BNTNF i;m told should be bought under .30
they have the goods people and cash and the rest should take care of itself....next leg up soon i agree...BNTNF"s mini bio in the making i like too..... good luck to all
I found this and called the IR contact...some real good people/story etc....and only .18 to boot! Seems like a mini biotech in the making...
Bontan Signs Letter Of Intent
TORONTO, March 26, 2013 /PRNewswire/ - Bontan Corporation Inc. ('the Company") (OTCBB: BNTNF) ("Bontan") is pleased to announce that it has signed a letter of intent with Portage Pharma Ltd., a private limited company formed under the laws of The British Virgin Islands ("Portage") to acquire all the issued and outstanding shares of Portage in exchange for approximately 81.7 million shares of Bontan. Approximately 71.4 million shares of Bontan, equal to the total number of warrants and options currently issued and outstanding in Bontan, will be reserved for the shareholders of Portage to be issued as warrants and options on terms to be mutually agreed upon at the time of Closing. Additionally, approximately 9.8 million shares of Bontan will be issued to Culminant Capital in consideration for financial advisory services rendered and to be rendered in connection with the proposed transaction and other transactions contemplated on Closing.
The Closing of the proposed transaction is subject to the completion of due diligence, execution of a definitive agreement and other approvals, expected to be completed by April 15, 2013.
Portage is a biotechnology company engaged in researching and developing products through to proof of concept with an early focus on unmet clinical needs and orphan drugs. Following proof of concept, Portage would look to sell or licence the products to Big Pharma.
Portage currently holds a master licence to the Antennapedia platform for all pathologies (except oncology).The board of directors and key shareholders of Portage are Dr. Gregory Bailey, Mr. Jim Mellon and Dr. Declan Doogan.
Portage has assembled a very experienced team of senior researchers and developers led by Dr. Bruce Littman, President and Chief Executive Officer, and Dr. Frank W. Marcoux, Chief Scientific Officer.
Dr. Doogan is Chairman of Portage and brings more than 30 years of experience in the global pharmaceuticals industry, including more than 20 years with Pfizer Inc., his last position being head of global drug development. Dr. Bruce Littman has extensive experience in the areas of translational research, personalised medicine and early clinical development planning and execution, including over 19 years with Pfizer Inc. at various levels of pharmaceutical drug development positions. Dr. Frank Marcoux has 25 years of experience in pharmaceutical research focusing on high confidence translation of drug discovery programs to early clinical proof of concept. Dr. Marcoux worked in various senior capacities with Pfizer Inc. for eight years and with Parke-Davis Pharmaceutical for seventeen years.
Mr. Kam Shah, Bontan CEO, comments; "We are delighted to report to our shareholders that, after a careful review, we have entered into a LOI to acquire Portage. The acquisition is a potential game-changer for us. It will put us at the forefront of biotech research and development. We are very much looking forward to completing our due diligence and closing this transaction and moving to the next phase of our plan."
Dr. Declan Doogan, the Chairman of Portage, states; "Portage represents a significant opportunity to bring exciting new medicines to the market. Using the strong scientific, medical and drug development expertise in the company we believe we can identify and develop novel approaches utilizing the latest in scientific theory. Under Bruce Littman we have an acknowledged leader in early drug development (Translational Medicine) and with the rest of the team we can exploit the exciting breakthroughs in biological and genetic sciences. Our first projects are already underway and could significantly add to the treatment of neurological and inflammatory disease. Bontan provides access to public markets and allows us to proceed expeditiously with our development of the Antennapedia platform while sourcing additional products."
About Bontan Corporation Inc:
Bontan Corporation Inc. recently concluded a settlement on its indirect oil and gas interest in Israel and now seeks business opportunities in biotechnology sector.
Investor relations contact John Robinson at (416) 860-0211.
back in six months to see as well....next pick is BNTNF in the bio world.....i'm told to buy big and soon see y'all
APPA has the cash to keep it alive for sure.....DARA has been on radar for some time>>>>>I'm suggesting a buy on BNTNF>>>>saw a crazy news release and called IR up in CA.....unreal!
...slightly official.:approved i hear
Bontan Corp (BNTNF.OB) at .11 has filed 2 PR's about a "move" into the biotech world. My guess is the next leg up in the stock is coming real soon and a technical analysis indicates the same....keep an eye on this one..i have been told a possible huge winner over the next 24 months. GL
news out..could this be enough to get it going?
looks like it's toast SEC should get around to it by 2020
are there 75 million shares out? if so perhaps a bunch today went into some good hands and hence you could see this a little higher
looks like they went another round with the SEC..nothing should happen until the reg stmnt is deemed effective and the "paper"gets freed up...
u a real Doc? if so call the IR guy at BNTNF.ob...i am and i did yesterday
i wonder why he never mentiond that 1 million is now going to be out towards an "aggressive pr campain as indicated in their news...i think a hard mailer is in the works.....
yet another 500k for PR...
On February 4, 2013, the Company sold an aggregate of 1,800,060 units (the “Units”) with gross proceeds to the Company of $450,015 to certain accredited investors (the “Investors”) pursuant to a subscription agreement (the “Subscription Agreement”). The proceeds from this offering will be used primarily for a future investor relations campaign
news out and should be good for a pop to 50
i'm gonna guess here at 3.10 its almost over
probably they throw in a big news release off th ehop as well...and then?
remarkable how it is holding in here....looks like a good push thru 2.25....and then?
news out this morning..should be good to pop her thru $1.00 imo
re the mailer....u could scan or give the gist..and perhaps target?...seems like real people on board....why they'd need to pay for hard mail i don't know...i'll look Chuck up and see wtf....
i.m told gnin subject of mail too...
can anybody post the mailer or target? thnks
question,..is there any possible news that could come out prior to the fda meeting?
i was able to yank this out of a company filing last year.:
On December 17, 2012, the Company entered into a consulting agreement (the "Consulting Agreement") with Antibes International Corp. ("Antibes") to provide management consulting, business advisory, shareholder information and public relations services to the Company. In connection with the Consulting Agreement, the Company paid Antibes $500,000 from the proceeds of a private placement that was completed on December 17, 2012.
it would suggest to me the stock my be subject of a large promo.